Atlas Trials

Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer

Clinical trial NCT05406635 · RECRUITING

Trial details

NCT number
NCT05406635
Sponsor
Odense University Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
CardiotoxicityHER2-positive Breast Cancer
Start date
2021-10-01
Primary completion
2026-02-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.